Globus Medical has been making waves in health, and for those following their journey, it’s been an exciting year. At The Healthcare Technology Report, we uncover the trends, strategies, and innovations shaping healthcare—and Globus Medical is making moves that deserve attention.
September 2023 was a turning point for Globus as they merged with NuVasive, creating a unified force that’s set to redefine innovation and leadership in the healthtech space. With this merger, Globus isn’t just growing—they’re building a powerhouse lineup that locks in their spot as a top player in the global musculoskeletal game.
The numbers back up the buzz. In Q4 2024 alone, Globus brought in a whopping $657 million in sales, pushing their full-year revenue to an impressive $2.52 billion—a 60.6% jump from the previous year. And they’re not slowing down. Projections for 2025 suggest $2.68 billion in sales and earnings. This is a company on the rise.
Their stock performance tells the same story. From a May breakout to a December peak, Globus’s stock jumped 70%. Now it’s sitting at a flat base just shy of its all-time high. Institutional investors are taking notice, driven by the company's impressive Q4 performance that smashed expectations.
